This inventor holds 2 USPTO granted patents. Top assignee: Fate Therapeutics, Inc.. Active years: 2016-2018.
Company Filing History:
Years Active: 2016-2018
Title: Monica Bennett: Innovator in Wnt Therapeutics
Introduction
Monica Bennett is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of Wnt polypeptides for therapeutic applications. With a total of 2 patents, her work focuses on innovative solutions for muscle loss and growth.
Latest Patents
Monica's latest patents include groundbreaking inventions related to Wnt compositions and their therapeutic uses. The first patent provides novel Wnt polypeptides that exhibit improved production characteristics, solubility, systemic delivery, and tissue uptake. These Wnt polypeptides can be utilized therapeutically to prevent or treat muscle loss and promote muscle hypertrophy and growth. The second patent also centers on Wnt polypeptides, emphasizing enhanced solubility and improved biologic drug-like properties, along with polynucleotides encoding these polypeptides.
Career Highlights
Monica Bennett is currently associated with Fate Therapeutics, Inc., where she continues to advance her research in the field of regenerative medicine. Her innovative work has positioned her as a key figure in the development of therapies aimed at muscle-related conditions.
Collaborations
Monica collaborates with esteemed colleagues such as Tom Tong Lee and Peter Flynn, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Monica Bennett's contributions to the field of biotechnology, particularly through her patents on Wnt polypeptides, highlight her role as a leading inventor in therapeutic innovations. Her work promises to make a significant impact on the treatment of muscle loss and growth.